Applied BioCode Submits BioCode® Respiratory Pathogen Panel (RPP) with KingFisher™ Nucleic Acid Extraction Claim to the FDA

SANTA FE SPRINGS, Calif.–(BUSINESS WIRE)–Applied BioCode, a leader in innovative molecular diagnostic solutions, announced today the submission of a new nucleic acid extraction claim for the KingFisher™ Flex Nucleic Acid Purification System in combination with the BioCode® Respiratory Pathogen Panel (RPP). This submission is aimed at expanding the use of the BioCode® RPP, enabling laboratories to further streamline workflows while maintaining high-quality, reliable results.


The new submission supports optimized extraction protocols on the KingFisher™ Flex system, providing laboratories with enhanced flexibility and efficiency for high-throughput respiratory pathogen testing. By pairing the proven capabilities of the BioCode® RPP with the KingFisher™ Flex system, labs can expect faster turnaround times, simplified processes, and consistent performance across multiple targets.

“Submitting this claim represents a significant step in our mission to support clinical laboratories with versatile, high-performance molecular testing solutions,” said Elisabeth Laderman, CSO. “This enhancement reinforces our commitment to enabling accurate and timely respiratory pathogen detection for high-volume testing environments.”

This submission builds on Applied BioCode’s prior FDA clearance of the BioCode® Gastrointestinal Pathogen Panel (GPP) with the KingFisher™ Flex system, demonstrating the company’s continued success in validating flexible, high-throughput extraction solutions across its multiplexed panel portfolio.

Applied BioCode continues to advance molecular diagnostic solutions that meet the evolving needs of clinical laboratories, supporting patient care with accurate, reliable, and actionable results.

About Applied BioCode

Applied BioCode is a leading provider of molecular diagnostic solutions, dedicated to delivering innovative technologies that empower laboratories, improve workflow efficiency, and enhance patient care.

For more information about the new nucleic acid extraction claim for BioCode® RPP or to learn more about Applied BioCode’s innovative diagnostic solutions, please visit https://www.apbiocode.com/products/.

Contacts

Media Contact:
Applied BioCode

Winston Ho

[email protected]

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Stay up-to-date with the latest Newsletters, free of charge.